Wed. 28 Feb 2024, 4:25pm ET
Benzinga
Earnings, News
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $0.91 by 3.3 percent. This is a 20.55 percent increase over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $178.10 million which beat the analyst consensus estimate of $175.67 million by 1.39 percent. This is a 31.91 percent increase over sales of $135.02 million the same period last year.